InveniAI Corporation CEO Krishnan Nandabalan sat down with Proactive at the 2019 BIO Investor Forum in San Francisco.
Connecticut-based InveniAI provides AI-driven technology solutions to help facilitate drug discovery. The company works with biopharmas that are in post-stage one phases.